Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …
Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections
Abstract Background The Infectious Diseases Society of America is committed to providing
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
up-to-date guidance on the treatment of antimicrobial-resistant infections. This guidance …
Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an
obstinate infectious agent. The scientific community is paying more attention to this …
obstinate infectious agent. The scientific community is paying more attention to this …
Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America …
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
[HTML][HTML] European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram …
Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …
[HTML][HTML] Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis
A Schmid, A Wolfensberger, J Nemeth, PW Schreiber… - Scientific reports, 2019 - nature.com
Infections caused by carbapenemase-producing, multidrug-resistant (MDR), or extensively
drug-resistant (XDR) Gram-negative bacteria constitute a major therapeutic challenge …
drug-resistant (XDR) Gram-negative bacteria constitute a major therapeutic challenge …
[HTML][HTML] Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and …
J Liu, Y Shu, F Zhu, B Feng, Z Zhang, L Liu… - Journal of global …, 2021 - Elsevier
Objectives This study aimed to compare the efficacy and safety of combination therapy with
high-dose sulbactam or colistin with additional antibacterial agents for treating multidrug …
high-dose sulbactam or colistin with additional antibacterial agents for treating multidrug …
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
O Zusman, S Altunin, F Koppel… - Journal of …, 2016 - academic.oup.com
Objectives The objective of this study was to summarize available data on polymyxin-based
combination therapy or monotherapy for carbapenem-resistant Gram-negative bacteria …
combination therapy or monotherapy for carbapenem-resistant Gram-negative bacteria …
Combination therapy for carbapenem-resistant Gram-negative bacteria
Carbapenem-resistant Gram-negative bacteria (CR-GNB) represent an increasing hazard in
healthcare settings. A central question concerning the treatment of invasive infections …
healthcare settings. A central question concerning the treatment of invasive infections …
[HTML][HTML] Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome …
F Kontopidou, H Giamarellou, P Katerelos… - Clinical microbiology …, 2014 - Elsevier
Infections due to carbapenem-resistant Klebsiella pneumoniae (CR-KP) have emerged as a
public health problem worldwide given their spread dynamics and the limited therapeutic …
public health problem worldwide given their spread dynamics and the limited therapeutic …